undamentalytics Newsletter
Sign in

Insulet Corporation cash flow statement

In fiscal 2025, Insulet Corporation's operations generated $569m of cash; it spent $192m on capital projects, leaving free cash flow of $378m. It returned $59.6m through buybacks.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash from operations−49−36−25−2939−131641369884−68119146430569511
Depreciation and amortisation559111212161414162855576373819099
Stock-based pay458101323192432382936344148696378
Capital spending37111171111227415716412911212376125192218
Free cash flow−52−42−37−40−4−3−23−6−33−122−65−45−180−470305378294
Free cash flow after stock pay−57−47−44−50−17−25−42−30−64−159−94−81−214−4522236315216
Share buybacks——————————————0060330
Shares issued9449551031285—0047800————

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: GMED vs PODDPODD vs RVTYPODD vs QDEL

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Insulet Corporation's SEC filings (10-K and 10-Q), retrieved October 20, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Insulet Corporation.